Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
2024 · The Lancet · 106 citations
https://doi.org/10.1016/s0140-6736(24)00921-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
110
Citations
2
h-index
1
i10-index
Kausik Chatterjee is an academic researcher from University of Liverpool. The author has contributed to research in topics: Acute Ischemic Stroke Management & Stroke Rehabilitation and Recovery & Cerebrovascular and Carotid Artery Diseases. The author has an h-index of 2, co-authored 6 publications.
https://doi.org/10.1016/s0140-6736(24)00921-8
https://doi.org/10.1001/jamaneurol.2025.4152
Click to start Chat